You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

Claims for Patent: 7,959,617

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,959,617

Title:	Devices and methods for delivering active agents to target sites
Abstract:	The subject invention provides novel, inexpensive, and highly effective methods and devices for convenient and effective wound irrigation. In one embodiment the subject invention provides a discharge means for a reservoir housing containing irrigation solution wherein the discharge means has one or more specifically designed nozzles through which a sufficient volume of the irrigation solution can pass at an appropriate pressure.
Inventor(s):	Rucinski; Paul J. (Gainesville, FL)
Assignee:	Innovation Technologies, Inc. (Gainesville, FL)
Application Number:	12/605,676
Patent Claims:	1. A wound irrigation device comprising a reservoir housing, containing a sterile aqueous wound irrigation solution that comprises an antiseptic agent, wherein said wound irrigation device comprises a discharge means that directs a stream of said wound irrigation solution when said reservoir housing is compressed, wherein said reservoir housing is made of a resilient compressible material, and wherein said antiseptic agent consists of chlorhexidine that is present at a concentration of 1% or less. 2. The wound irrigation device, according to claim 1, which contains from 250 ml to 750 ml of wound irrigation solution. 3. The wound irrigation device according to claim 1, wherein said device further comprises a backsplash shield. 4. The device, according to claim 1, wherein the biologically active agent is chlorhexidine at a concentration of 0.05% or less. 5. The device, according to claim 1, wherein the chlorhexidine is in the form of chlorhexidine gluconate. 6. The device, according to claim 1, wherein the pH of the irrigation solution is between pH 5.5 and pH 7.0. 7. The device, according to claim 1, wherein the chlorhexidine is at a concentration of about 0.05%. 8. The device, according to claim 1, wherein said wound irrigation fluid consists of sterile water and chlorhexidine at a concentration of about 0.05%.

Details for Patent 7,959,617

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006	⤷ Try a Trial	2026-12-19
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.